The following is the commnication I had with AZ Rep Ted Downing last night and this morning in the lead up to the vote on HB 2637. It begins with his response to my general mail I sent to all the reps, which is above.
Dear Peter Passaro,
Thank you for your comments. The issue is not whether or not there is a
complaint. To me, it is an issue of scientific credibility. Help me on
this, please. Can you name a faculty researcher from either the University
of Arizona or Arizona State University who is working with you at Alcor Life
Extension Foundation? And can you name an article published in Science or
Nature, the two major peer reviewed scientific journals supporting your
theory of life extension?
Ted Downing
State Representive
Tucson
>>>>>
Dear Mr. Downing,
Speaking as neuroscientist, I believe there is no better than a fifty
percent
chance that patients suspended will be able to be revived after using the
most
advanced cryonics methods currently available. That said, I choose to take
that chance based on the fact that to my mind this funeral technique is no
less dignified than burial or cremation and offers a possibility of revival.
Alcor makes every effort to use the latest available technologies, and these
are improving constantly. Cryobiology is a very small field worldwide and
most
of the cutting edge research is carried out in private laboratories. I am
not
familiar with the researchers at Arizona universities, but here at Georgia
Tech there is cutting edge research on cryobiology for storing human organs
for transplant. This research is directly increasing the possibilities of
success for cryonics and provides a great boon to mankind in increasing the
number of organs available for lifesaving operations. Please see the end of
this message for a reputable scientific publication list on the viability of
current cryonic techniques for storage of biological tissue.
I am extensively familiar with this literature and as an expert in human
aging, physiology, and neurology I would be willing to guide you through it
and give you my most honest assessment of the technology and the potential
for
cryonic suspension and revival of humans. I was previously an analyst (and
Vice President) for a venture capital company where it was my job to assess
the viability and commercial potential of emerging medical technologies, so
this is not just me shooting from the hip.
All of the above was not the point of my message though. What I wanted to
make clear was that it is my right as an individual to choose the method of
my
own funerary rites, whether it be cremation, burial, or cryonic storage.
The
passage of HB 2637 would deny me the right to make that choice by preventing
the effective operation of what I believe to be the only competent provider
of
this service in the world. There is no evidence that Alcor has ever
provided
anything but the best of care to any of their clients, so I fail to see the
interest of the state in preventing individuals from being able to use their
services by way of over-regulation.
In addition, passage of this bill would make Arizona unattractive to
organizations and individuals peforming cutting edge biomedical research
because of the likelihood that they would experience unnecessary bureacratic
red tape in carrying out research activities.
If you believe cryonics needs to be further regulated in your state, I would
respectfully ask that you create meaningful legislation instead of HB 2637,
which serves no one's interests and detrimentally affects the human rights
of
many.
Sincerely,
Peter A Passaro
ppassaro@neuro.gatech.edu
http://www.neuro.gatech.edu <
http://www.neuro.gatech.edu> Laboratory for Neuroengineering
Georgia Institue of Technology
Atlanta, Ga 30332
Publications List:
Arnaud FG, Khirabadi B, Fahy GM.
Physiological evaluation of a rabbit kidney perfused with VS41A.
Cryobiology. 2003 Jun;46(3):289-94.
PMID: 12818220 [PubMed - indexed for MEDLINE]
Kheirabadi BS, Fahy GM.
Permanent life support by kidneys perfused with a vitrifiable (7.5 molar)
cryoprotectant solution.
Transplantation. 2000 Jul 15;70(1):51-7.
PMID: 10919575 [PubMed - indexed for MEDLINE]
Wowk B, Leitl E, Rasch CM, Mesbah-Karimi N, Harris SB, Fahy GM.
Vitrification enhancement by synthetic ice blocking agents.
Cryobiology. 2000 May;40(3):228-36.
PMID: 10860622 [PubMed - indexed for MEDLINE]
Fahy GM, Ali SE.
Cryopreservation of the mammalian kidney. II. Demonstration of immediate ex
vivo function after introduction and removal of 7.5 M cryoprotectant.
Cryobiology. 1997 Sep;35(2):114-31.
PMID: 9299103 [PubMed - indexed for MEDLINE]
Fahy GM, Saur J, Williams RJ.
Physical problems with the vitrification of large biological systems.
Cryobiology. 1990 Oct;27(5):492-510.
PMID: 2249453 [PubMed - indexed for MEDLINE]
Ruggera PS, Fahy GM.
Rapid and uniform electromagnetic heating of aqueous cryoprotectant
solutions
from cryogenic temperatures.
Cryobiology. 1990 Oct;27(5):465-78.
PMID: 2249450 [PubMed - indexed for MEDLINE]
Fahy GM, Levy DI, Ali SE.
Some emerging principles underlying the physical properties, biological
actions, and utility of vitrification solutions.
Cryobiology. 1987 Jun;24(3):196-213.
PMID: 3595164 [PubMed - indexed for MEDLINE]
Fahy GM.
Vitrification: a new approach to organ cryopreservation.
Prog Clin Biol Res. 1986;224:305-35. Review. No abstract available.
PMID: 3540994 [PubMed - indexed for MEDLINE]
Rall WF, Fahy GM.
Ice-free cryopreservation of mouse embryos at -196 degrees C by
vitrification.
Nature. 1985 Feb 14-20;313(6003):573-5.
PMID: 3969158 [PubMed - indexed for MEDLINE]
Fahy GM, MacFarlane DR, Angell CA, Meryman HT.
Vitrification as an approach to cryopreservation.
Cryobiology. 1984 Aug;21(4):407-26. No abstract available.
PMID: 6467964 [PubMed - indexed for MEDLINE]
>>>>>
Dear Peter Passaro,
Apart almost 20 year old article from the Rall WF, Fahy GM. article on
Ice-free cryopreservation of mouse embryos at -196 degrees C by
vitrification.Nature. 1985 Feb 14-20;313(6003):573-5, you did not answer my
original question (see below). Are you saying that the activites at Alcor
in Arizona are focused on harvesting organ transplants? Is that the contract
that Alcor signs with its clients? There seems to be a difference between
storing organs and bodies of clients who have the expectation of coming back
to life.
Ted Downing
State Representative
PS. Are you on the faculty at GIT?
>>>>>
Dear Mr. Downing,
I tried to answer your question by expressing to you that this is an active
area of research in the scientific literature. Science and Nature are
extremely conservative journals and would not publish something of this nature
until such time as the debate is settled, but that there is a very clear track
record of increasing success of cryonics in the peer reviewed literature.
An emphatic NO on Alcor harvesting organs, they have never been part of any
such activities and always treat their clients with utmost of respect and
care. I was simply pointing out that because the scientific field of low
temperature organ storage and revival is achieving great success, it is not
too great a jump from storing tissues to cryogenically suspending and reviving
people.
Alcor has been quite clear with me and all their clients that this is still a
speculative area of research, and that there is no guarantee of success. The
point of both my previous messages is that even though I am not completely
convinced curent techniques will be able to allow possible revival, I still
choose this method of funeral and expect it to be carried out with the
greatest of possible technical skill. Passing HB 2637 will likely take away
that choice from me and many others.
As to my credentials - I have a BS in microbiology, an MS in molecular
neuroscience, extensive training in human biology of aging, physiology, and
biochemistry. I was previously a biotechnology industry analyst for a number
of years and a staff scientist for UCLA. At Georgia Tech, I am not faculty,
but I am a very active researcher. I am 2 years into completing my
neuroengineering doctorate and my research gives me unique expertise in
commenting on the viability of neural tissue after long term storage.
Sincerely,
Peter Passaro
ppassaro@neuro.gatech.edu
http://www.neuro.gatech.eduLaboratory for Neuroengineering
Georgia Institue of Technology
Atlanta, Ga 30332